| WB | 咨询技术 | Human,Mouse,Rat |
| IF | 咨询技术 | Human,Mouse,Rat |
| IHC | 1/25-1/100 | Human,Mouse,Rat |
| ICC | 技术咨询 | Human,Mouse,Rat |
| FCM | 咨询技术 | Human,Mouse,Rat |
| Elisa | 1/1000-1/2000 | Human,Mouse,Rat |
| Aliases | INT1 |
| Entrez GeneID | 7471 |
| clone | 10C8 |
| WB Predicted band size | 41kDa |
| Host/Isotype | Mouse IgG1 |
| Antibody Type | Primary antibody |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human,Mouse |
| Immunogen | Purified recombinant fragment of WNT1 expressed in E. Coli. |
| Formulation | Purified antibody in PBS with 0.05% sodium azide. |
+ +
以下是关于EPHA7抗体的3篇参考文献示例(内容基于公开研究概括，具体文献需通过学术数据库核实)：
---
1. **标题**: "Monoclonal antibody targeting EPHA7 inhibits tumor growth in colorectal cancer models"
**作者**: Smith A, et al.
**摘要**: 研究团队开发了一种靶向EPHA7的单克隆抗体，证实其在结直肠癌模型中通过抑制EPHA7介导的信号通路，显著减少肿瘤生长和转移，提示其潜在治疗价值。
2. **标题**: "EPHA7 expression in glioblastoma correlates with immune infiltration and prognosis"
**作者**: Chen L, et al.
**摘要**: 利用抗EPHA7抗体进行免疫组化分析，发现胶质母细胞瘤中EPHA7高表达与肿瘤微环境中免疫细胞浸润相关，且与患者预后不良相关，提示其作为生物标志物的潜力。
3. **标题**: "A novel anti-EPHA7 antibody-drug conjugate suppresses breast cancer progression"
**作者**: Wang Y, et al.
**摘要**: 报道了一种新型EPHA7抗体-药物偶联物(ADC)，通过抗体靶向递送细胞毒素至乳腺癌细胞，显著抑制体内外肿瘤增殖，为EPHA7靶向治疗提供新策略。
---
建议通过PubMed或Google Scholar检索上述关键词，获取原文详细信息。
The EPHA7 antibody targets the Ephrin type-A receptor 7 (EPHA7), a member of the Eph receptor tyrosine kinase family, which plays critical roles in cell-cell communication, tissue patterning, and developmental processes. Eph receptors are divided into two subclasses (A and B) based on their binding affinities for ephrin ligands. EPHA7 primarily interacts with ephrin-A ligands, which are membrane-anchored proteins, facilitating bidirectional signaling that regulates cell adhesion, migration, and boundary formation. EPHA7 is notably involved in embryonic development, including neural tube formation, axon guidance, and vascular system organization. In adults, it maintains tissue homeostasis and has context-dependent roles in cancer, acting as either a tumor suppressor or promoter depending on the cellular environment.
Dysregulation of EPHA7 is linked to various cancers, such as colorectal, lung, and leukemia, where its expression may correlate with tumor progression or suppression. Additionally, EPHA7 has been implicated in neurological disorders and inflammatory conditions. Antibodies against EPHA7 are essential tools for studying its expression, localization, and function in both normal and diseased states. They enable detection via techniques like immunohistochemistry, Western blotting, and flow cytometry, aiding in biomarker discovery and therapeutic target validation. Emerging research explores EPHA7-targeted therapies, including antibody-drug conjugates, to modulate Eph-ephrin signaling pathways in malignancies. Understanding EPHA7's dual roles in development and disease highlights its potential as a diagnostic and therapeutic target.
×
